Status:
SUSPENDED
Aromatherapy Oil Associated for Managing Anxiety and Pain During Bone Marrow Biopsy Procedures
Lead Sponsor:
City of Hope Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial evaluates whether using aromatherapy can reduce pain and anxiety for cancer patients during routine biopsy procedures. Because of the discomfort associated with a bone marrow aspir...
Detailed Description
PRIMARY OBJECTIVES: I. To determine the feasibility of utilizing aromatherapy oils during bone marrow biopsy procedures in clinical practice. II. To assess satisfaction of patients receiving aromath...
Eligibility Criteria
Inclusion
- Patients must have the ability to understand and sign a written informed consent document, and be willing to follow protocol requirements
- Ability to read and understand English for patient reported outcomes
- Age \>= 18 years
- Eastern Cooperative Oncology Group (ECOG) performance status ≤ 1
- Willingness to comply with all study interventions of essential oil aromatherapy
- Anxiety \> 3 on a 0-10 visual analog scale regarding the bone marrow biopsy/aspirate procedure
- The study is open to all participants regardless of gender, race, or ethnicity
Exclusion
- Allergy to lavender oil, linalool oil, jojoba oil
- Previous enrollment in this study
- Uncontrolled respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD)
- Mental incapacitation (ex. stroke, brain metastasis etc.) that would cause inability to follow directions, in the opinion of the investigators
- Ongoing uncontrolled active psychiatric condition that would interfere in the conduct of the study (e.g., mood disorders, anxiety, psychosis disorders, or substance use), as determined by the patient's primary cancer team.
- If a patient has a history of a psychiatric disorder, we will contact their primary cancer team to determine if their condition is controlled or uncontrolled, and if it will interfere with the study
- Recent changes in the past 2 weeks to medications prescribed for pain or anxiety
- Abnormal smelling abilities due to sinus infections, long COVID, etc.
Key Trial Info
Start Date :
August 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 25 2026
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06581211
Start Date
August 23 2024
End Date
June 25 2026
Last Update
November 6 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope Medical Center
Duarte, California, United States, 91010
2
City of Hope at Lennar
Irvine, California, United States, 92618